Tagged Articles

oral contraceptives 114 articles

Bayer shells out millions to settle more Yaz lawsuits

Bayer, maker of the blockbuster birth control pills Yaz and Yasmin, will pay at least $120 million to settle about 500 lawsuits claiming that the pills caused dangerous and sometimes deadly blood clots. The settlement is the first wave of resolutions expected from Bayer over its oral contraceptives. Bayer officials said the company agreed to pay an average of about $220,000 per case to resolve the lawsuits. The case was the first set for trial of more than 11,000 lawsuits over injuries allegedly caused by the drugs. The settlement comes just days after the Food and Drug Administration (FDA) ordered ... Read More

FDA puts stronger blood clot warnings on Yaz, Yasmin birth control pills

Yaz and other newer birth control pills that contain the hormone drospirenone will get stronger warnings on their labels warning users that the drugs may be more likely than older oral contraceptives to cause blood clots, the Food and Drug Administration (FDA) announced. The new labeling will apply to Yaz, Yasmin, Beyaz, and Safyral, which are all made by Bayer. The pills are among the top selling oral contraceptives in the United States. They were marketed not only as a drug to prevent pregnancy, but also as a medication to help clear up acne and ease symptoms of premenstrual disorders. ... Read More

Bayer settles a small fraction of Yaz, Yasmin lawsuits

Bayer has agreed to settle about 70 of the approximately 11,300 lawsuits against the drug giant involving its blockbuster birth control pills Yaz and Yasmin, according to the company’s 2011 annual report. The terms of the settlement were not disclosed, but Bayer reportedly said the conditions were reasonable. The lawsuits were filed on behalf of plaintiffs who allege that using the oral contraceptives, as well as their generic equivalents Ocella and Gianvi, caused them or a loved one serious injury or death. The birth control pills contain the hormone drospirenone which recent studies have found put women at greater risk ... Read More

Panel members had financial ties to Yaz maker

Why are the birth control pills Yaz and Yasmin still on the market when studies show they are more dangerous than other oral contraceptives? Consumer watchdog group Project on Government Oversight, or POGO, claims the government’s expert panel charged with reviewing safety data on the top selling birth control pills was compromised because four members had financial ties to Bayer, the pharmaceutical company that makes the pills. The situation was a long time coming. Just as Bayer was enjoying large profits from its newer generation birth control pills and actively working to push back generic competition while formulating new folic ... Read More

Generic Yaz will include same blood clot warnings

Watson Pharmaceuticals has launched Vestura, a generic version of Bayer’s blockbuster birth control pill Yaz. Like their brand-name counterpart, these pills will also carry a safety announcement on their packaging, warning users that studies suggest the drospirenone-containing pills may put users at greater risk for developing life threatening blood clots. Yaz, as well as the brands Yasmin, Beyaz, Safyral, and other generic varieties, combine the hormones drospirenone and ethinyl estradiol. Yaz and its generic versions had sales of about $510 million last year alone. Watson hopes to take a bite out of those profits. However, just as Watson was vying ... Read More

Long flights, birth control pills increase blood clot risk

Flying coach instead of first-class does not increase your chances of developing blood clots, according to new guidelines from the American College of Chest Physicians. But flying with risk factors may increase your chance of getting the potentially deadly condition. People who fly are warned that sitting in one place for too long without walking around and stretching their legs can make them more susceptible to blood clots, a situation that has been nicknamed “economy class syndrome.” The idea is that roomier first-class seats offer more space for frequent movement and are safer, but the new guidelines put that myth to ... Read More

Experimental contraceptive zaps sperm count in rats

Male contraception may be as easy as a couple zaps of ultrasound to the testicles, according to a new study published in the journal Reproductive Biology and Endocrinology. Researchers from the University of North Carolina at Chapel Hill found that zapping the testicles of rats with ultrasound machines like the ones physical therapists use to treat muscle injuries, did away with sperm-producing cells. The most effective dosage was determined to be two 15-minute zap sessions, which sent rat sperm counts far below the range considered normal in fertile rats in just two week’s time. While the test shows promise for ... Read More

Yaz lawyers oppose former FDA chief’s testimony

Drug giant Bayer is not at all happy that a former Food and Drug Administration (FDA) chief has been tapped to testify against the drug company in a multidistrict litigation (MDL) focusing on the safety of Bayer’s top-selling birth control pills, Yaz. Former FDA commissioner Dr. David Kessler recently submitted an expert report claiming that an FDA advisory committee vote on the pills was tainted because some members of the panel were paid consultants for Bayer and posed an obvious conflict of interest. Thousands of women have joined the lawsuit against Yaz, alleging that Yaz caused serious side effects including ... Read More

FDA panel member ‘well utilized’ by Yaz maker

A Food and Drug Administration (FDA) panel member who voted to keep the birth control pills Yaz and Yasmin on the market despite studies that showed the pills put women at greater risk for deadly blood clots was praised by the drugs’ maker Bayer in a 2008 report saying, “She will be well utilized.” The adviser, Paula Hillard, M.D., with Stanford’s School of Medicine, is listed on the medical school’s website as a paid consultant receiving $5,000 or more annually from a division of Bayer. Hillard’s apparent conflict of interest on the federal agency panel was noted by former FDA ... Read More

Watchdog group pushes FDA panel to revote on Yaz safety

A consumer watchdog group is calling for a revote by a Food and Drug Administration (FDA) advisory panel, after discovering that some members of the panel had ties to drug companies that made the pills under review. The FDA panel was charged with reviewing studies that showed a newer generation of birth control pills containing the hormone drospirenone put women at greater risk for life threatening blood clots than other oral contraceptives with other hormones. Drospirenone-containing pills include Yaz and Yasmin, made by Bayer. The drug company also sells versions of the pills containing folic acid under the brand names ... Read More